NASDAQ:ITCI - Intra-Cellular Therapies Price Target & Analyst Ratings

$8.49
-0.18 (-2.08 %)
(As of 08/25/2019 03:05 PM ET)
Today's Range
$8.47
Now: $8.49
$8.76
50-Day Range
$7.83
MA: $9.88
$13.46
52-Week Range
$7.41
Now: $8.49
$23.62
Volume458,629 shs
Average Volume732,162 shs
Market Capitalization$468.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.18

Analyst Ratings

Intra-Cellular Therapies (NASDAQ:ITCI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Intra-Cellular Therapies in the last 12 months. Their average twelve-month price target is $25.4286, suggesting that the stock has a possible upside of 199.51%. The high price target for ITCI is $31.00 and the low price target for ITCI is $16.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.4286$30.40$31.00$29.7143
Price Target Upside: 199.51% upside190.08% upside137.00% upside94.34% upside

Intra-Cellular Therapies (NASDAQ:ITCI) Consensus Price Target History

Intra-Cellular Therapies (NASDAQ:ITCI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/12/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$16.00 ➝ $16.00LowView Rating Details
8/8/2019JMP SecuritiesLower Price TargetMarket Outperform$24.00 ➝ $21.00HighView Rating Details
8/7/2019Royal Bank of CanadaSet Price TargetBuy$26.00LowView Rating Details
7/8/2019CowenReiterated RatingBuy$28.00HighView Rating Details
5/23/2019Cantor FitzgeraldReiterated RatingOverweight$26.00 ➝ $29.00MediumView Rating Details
12/12/2018Canaccord GenuitySet Price TargetBuy$31.00LowView Rating Details
11/13/2018Leerink SwannInitiated CoverageOutperform$27.00MediumView Rating Details
3/2/2018SunTrust BanksReiterated RatingBuy$28.00LowView Rating Details
2/26/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$25.00HighView Rating Details
9/8/2017BTIG ResearchReiterated RatingBuy$36.00MediumView Rating Details
9/7/2017Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$14.00 ➝ $33.00HighView Rating Details
(Data available from 8/25/2017 forward)
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel